Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.290
Neutral
RSI(14)
72.439
Buy
STOCH(KDJ)(9,3,3)
47.443
Neutral
ATR(14)
1.069
Low Volatility
CCI(14)
30.011
Neutral
Williams %R
52.700
Neutral
TRIX(12,20)
1.751
Sell
StochRSI(14)
54.941
Buy
CeriBell Inc
CBLL21.420USD
+0.130+0.61%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
793.58MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of CeriBell Inc
Currency: USD Updated: 2025-12-23Key Insights
CeriBell Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 39/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 26.00.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
CeriBell Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
8
analysts
Strong Buy
Current Rating
26.000
Target Price
+28.59%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
CeriBell Inc Highlights
StrengthsRisks
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 152.47% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 65.44M.
Fairly Valued
The company’s latest PE is -15.13, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 30.92M shares, decreasing 0.09% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 2.34K shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-23The current financial score of CeriBell Inc is 7.25, ranking 96/208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 22.59M, representing a year-over-year increase of 31.37%, while its net profit experienced a year-over-year increase of 29.26%.
Score
Financials
8.18
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.42
Operational Efficiency
5.54
Growth Potential
7.92
Shareholder Returns
7.19
CeriBell Inc's Company Valuation
Currency: USD Updated: 2025-12-23The current valuation score of CeriBell Inc is 7.26, ranking 105/208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -15.13, which is -46.44% below the recent high of -8.11 and -88.04% above the recent low of -28.46.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 39/208
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-23The current earnings forecast score of CeriBell Inc is 9.25, ranking 4/208 in the Healthcare Equipment & Supplies industry. The average price target for CeriBell Inc is 29.00, with a high of 32.00 and a low of 17.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
8
analysts
Strong Buy
Current Rating
26.000
Target Price
+28.59%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
90
Total
4
Median
7
Average
Company name
Ratings
Analysts
CeriBell Inc
CBLL
8
Boston Scientific Corp
BSX
36
Veeva Systems Inc
VEEV
34
Intuitive Surgical Inc
ISRG
34
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
27
1
2
3
...
18
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-23The current price momentum score of CeriBell Inc is 8.87, ranking 33/208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 25.02 and the support level at 16.79, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
21.270
Buy
MA10
21.317
Buy
MA20
19.953
Buy
MA50
15.702
Buy
MA100
13.858
Buy
MA200
15.551
Buy
Institutional Confidence
Currency: USD Updated: 2025-12-23The current institutional shareholding score of CeriBell Inc is 7.00, ranking 82/208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 84.91%, representing a quarter-over-quarter decrease of 0.14%. The largest institutional shareholder is The Vanguard, holding a total of 1.47M shares, representing 3.97% of shares outstanding, with 106.71% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Fidelity Management & Research Company LLC
TPG Capital, L.P.
Longitude Capital Management Co., LLC
Global Value Investment Portfolio Management Pte. Ltd.
Red Tree Management, LLC
Parvizi (Josef)
Ally Bridge Group (HK) Limited
BlackRock Institutional Trust Company, N.A.
Chao (Xingjuan)
1
2
Risk Assessment
Currency: USD Updated: 2025-12-23The current risk assessment score of CeriBell Inc is 4.87, ranking 91/208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
+57.24%
240-Day Volatility
+69.73%
Return
Best Daily Return
60 days
+11.88%
120 days
+11.88%
5 years
--
Worst Daily Return
60 days
-6.79%
120 days
-15.25%
5 years
--
Sharpe Ratio
60 days
+4.58
120 days
+0.76
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+57.24%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
-0.13
3 years
--
5 years
--
Skewness
240 days
-1.07
3 years
--
5 years
--
Volatility
Realised Volatility
240 days
+69.73%
5 years
--
Standardised True Range
240 days
+4.44%
5 years
--
Downside Risk-Adjusted Return
120 days
+110.80%
240 days
+110.80%
Maximum Daily Upside Volatility
60 days
+57.25%
Maximum Daily Downside Volatility
60 days
+33.76%
Liquidity
Average Turnover Rate
60 days
+0.91%
120 days
+0.90%
5 years
--
Turnover Deviation
20 days
--
60 days
--
120 days
--
Peer Comparison
Healthcare Equipment & Supplies
CeriBell Inc
CBLL
7.71 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
TCMD
8.45 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AXGN
8.41 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
UFP Technologies Inc
UFPT
8.31 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of CeriBell Inc?
The TradingKey Stock Score provides a comprehensive assessment of CeriBell Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of CeriBell Inc’s performance and outlook.
How do we generate the financial health score of CeriBell Inc?
To generate the financial health score of CeriBell Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects CeriBell Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of CeriBell Inc.
How do we generate the company valuation score of CeriBell Inc?
To generate the company valuation score of CeriBell Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare CeriBell Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of CeriBell Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of CeriBell Inc.
How do we generate the earnings forecast score of CeriBell Inc?
To calculate the earnings forecast score of CeriBell Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on CeriBell Inc’s future.
How do we generate the price momentum score of CeriBell Inc?
When generating the price momentum score for CeriBell Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of CeriBell Inc’s prices. A higher score indicates a more stable short-term price trend for CeriBell Inc.
How do we generate the institutional confidence score of CeriBell Inc?
To generate the institutional confidence score of CeriBell Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about CeriBell Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of CeriBell Inc.
How do we generate the risk management score of CeriBell Inc?
To assess the risk management score of CeriBell Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of CeriBell Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of CeriBell Inc.
